クオリプスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/05/09 | 3,350 | 3,475 | 3,340 | 3,460 | +80 | +2.4% | 61,300 |
| 2024/05/08 | 3,460 | 3,465 | 3,350 | 3,380 | -120 | -3.4% | 85,300 |
| 2024/05/07 | 3,565 | 3,585 | 3,455 | 3,500 | -45 | -1.3% | 82,100 |
| 2024/05/02 | 3,445 | 3,560 | 3,435 | 3,545 | +65 | +1.9% | 63,600 |
| 2024/05/01 | 3,400 | 3,515 | 3,355 | 3,480 | +45 | +1.3% | 96,600 |
| 2024/04/30 | 3,345 | 3,460 | 3,275 | 3,435 | +110 | +3.3% | 77,500 |
| 2024/04/26 | 3,520 | 3,525 | 3,270 | 3,325 | +15 | +0.5% | 155,800 |
| 2024/04/25 | 3,410 | 3,410 | 3,310 | 3,310 | -150 | -4.3% | 86,300 |
| 2024/04/24 | 3,495 | 3,495 | 3,385 | 3,460 | +35 | +1% | 69,900 |
| 2024/04/23 | 3,430 | 3,540 | 3,420 | 3,425 | +5 | +0.1% | 68,600 |
| 2024/04/22 | 3,320 | 3,440 | 3,260 | 3,420 | +170 | +5.2% | 102,200 |
| 2024/04/19 | 3,400 | 3,420 | 3,140 | 3,250 | -210 | -6.1% | 279,400 |
| 2024/04/18 | 3,500 | 3,500 | 3,370 | 3,460 | -155 | -4.3% | 264,000 |
| 2024/04/17 | 3,750 | 3,755 | 3,610 | 3,615 | -130 | -3.5% | 164,500 |
| 2024/04/16 | 3,800 | 3,920 | 3,720 | 3,745 | -70 | -1.8% | 154,800 |
| 2024/04/15 | 3,700 | 3,880 | 3,690 | 3,815 | +85 | +2.3% | 148,200 |
| 2024/04/12 | 3,740 | 3,830 | 3,665 | 3,730 | +50 | +1.4% | 119,900 |
| 2024/04/11 | 3,635 | 3,705 | 3,575 | 3,680 | +30 | +0.8% | 115,600 |
| 2024/04/10 | 3,990 | 4,065 | 3,630 | 3,650 | -340 | -8.5% | 343,500 |
| 2024/04/09 | 4,020 | 4,075 | 3,900 | 3,990 | -30 | -0.7% | 228,000 |
| 2024/04/08 | 3,815 | 4,035 | 3,790 | 4,020 | +270 | +7.2% | 337,700 |
| 2024/04/05 | 3,630 | 3,770 | 3,630 | 3,750 | +55 | +1.5% | 135,500 |
| 2024/04/04 | 3,720 | 3,730 | 3,580 | 3,695 | -10 | -0.3% | 136,900 |
| 2024/04/03 | 3,600 | 3,790 | 3,575 | 3,705 | +90 | +2.5% | 207,300 |
| 2024/04/02 | 3,785 | 3,785 | 3,580 | 3,615 | -135 | -3.6% | 116,000 |
| 2024/04/01 | 3,680 | 3,790 | 3,630 | 3,750 | +55 | +1.5% | 125,900 |
| 2024/03/29 | 3,700 | 3,875 | 3,620 | 3,695 | +25 | +0.7% | 231,100 |
| 2024/03/28 | 3,365 | 3,700 | 3,365 | 3,670 | +285 | +8.4% | 231,000 |
| 2024/03/27 | 3,420 | 3,495 | 3,380 | 3,385 | -50 | -1.5% | 78,600 |
| 2024/03/26 | 3,310 | 3,435 | 3,275 | 3,435 | +60 | +1.8% | 97,600 |
| 2024/03/25 | 3,350 | 3,430 | 3,295 | 3,375 | -5 | -0.1% | 99,800 |
| 2024/03/22 | 3,520 | 3,520 | 3,355 | 3,380 | -125 | -3.6% | 132,900 |
| 2024/03/21 | 3,420 | 3,585 | 3,365 | 3,505 | +85 | +2.5% | 170,900 |
| 2024/03/19 | 3,320 | 3,460 | 3,270 | 3,420 | +100 | +3% | 131,300 |
| 2024/03/18 | 3,290 | 3,370 | 3,160 | 3,320 | -15 | -0.4% | 193,800 |
| 2024/03/15 | 3,580 | 3,580 | 3,305 | 3,335 | -335 | -9.1% | 386,200 |
| 2024/03/14 | 3,595 | 3,860 | 3,475 | 3,670 | +175 | +5% | 561,100 |
| 2024/03/13 | 3,625 | 3,625 | 3,400 | 3,495 | -30 | -0.9% | 154,400 |
| 2024/03/12 | 3,375 | 3,600 | 3,300 | 3,525 | +100 | +2.9% | 166,300 |
| 2024/03/11 | 3,630 | 3,680 | 3,400 | 3,425 | -345 | -9.2% | 321,100 |
| 2024/03/08 | 3,675 | 3,930 | 3,670 | 3,770 | +95 | +2.6% | 344,600 |
| 2024/03/07 | 3,900 | 3,930 | 3,650 | 3,675 | -150 | -3.9% | 311,600 |
| 2024/03/06 | 3,615 | 3,915 | 3,525 | 3,825 | +85 | +2.3% | 369,300 |
| 2024/03/05 | 3,400 | 3,800 | 3,355 | 3,740 | +390 | +11.6% | 378,200 |
| 2024/03/04 | 3,280 | 3,375 | 3,205 | 3,350 | +130 | +4% | 129,700 |
| 2024/03/01 | 3,180 | 3,265 | 3,060 | 3,220 | +20 | +0.6% | 157,200 |
| 2024/02/29 | 3,285 | 3,325 | 3,185 | 3,200 | -85 | -2.6% | 139,000 |
| 2024/02/28 | 3,395 | 3,465 | 3,230 | 3,285 | -115 | -3.4% | 207,000 |
| 2024/02/27 | 3,475 | 3,495 | 3,360 | 3,400 | -20 | -0.6% | 132,000 |
| 2024/02/26 | 3,300 | 3,500 | 3,205 | 3,420 | +175 | +5.4% | 201,500 |
1～
50
件表示中 / 212件
類似銘柄と比較する
現在ご覧いただいている「クオリプス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| クオリプス | 350,000円 | -15.8% | - | 0.00% | - | 4.51倍 |
|
大阪大学発ベンチャー。ｉＰＳ細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
| ステムリム | 47,400円 | -14.9% | -31.0% | 0.00% | 194.26倍 | 3.40倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| サンバイオ | 42,300円 | - | - | 0.00% | - | 11.23倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 扶桑薬 | 225,000円 | +4.5% | -9.7% | 3.11% | 14.79倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| 大幸薬品 | 35,200円 | +11.1% | - | 0.00% | 32.12倍 | 2.62倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
